Anti-dementia drugs are a class of drugs used to slow down or improve cognitive dysfunction associated with dementia. Dementia is a chronic, progressive neurodegenerative disease characterized by a gradual decline in memory, thinking ability, language ability, and executive function, and is common in Alzheimer's disease, vascular dementia, Lewy body dementia, etc.

The global Anti-dementia Drugs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.

North American market for Anti-dementia Drugs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for Anti-dementia Drugs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The major global manufacturers of Anti-dementia Drugs include Jiangsu Hausen Pharmaceutical Group Co., Ltd., Zhien Biotechnology Co., Ltd., Zhejiang Huahai Pharmaceutical Co., Ltd., Jinri Pharmaceutical (China) Co., Ltd., Shandong Luoxin Pharmaceutical Group Co., Ltd., Chengdu Tongde Pharmaceutical Co., Ltd., Disa Pharmaceutical Group Co., Ltd., Zhejiang Hisun Pharmaceutical Co., Ltd., Zhejiang Yixin Pharmaceutical Co., Ltd., Yichang Dongyangguang Changjiang Pharmaceutical Co., Ltd., etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Anti-dementia Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Anti-dementia Drugs.

The Anti-dementia Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Anti-dementia Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Anti-dementia Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Anti-dementia Drugs Market Report

Report Metric	Details
Report Name	Anti-dementia Drugs Market
Segment by Type	Donepezil Galantamine Rivastigmine Memantine Other
Segment by Application	Hospital Clinic Pharmacy Other
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Jiangsu Hausen Pharmaceutical Group Co., Ltd., Zhien Biotechnology Co., Ltd., Zhejiang Huahai Pharmaceutical Co., Ltd., Jinri Pharmaceutical (China) Co., Ltd., Shandong Luoxin Pharmaceutical Group Co., Ltd., Chengdu Tongde Pharmaceutical Co., Ltd., Disa Pharmaceutical Group Co., Ltd., Zhejiang Hisun Pharmaceutical Co., Ltd., Zhejiang Yixin Pharmaceutical Co., Ltd., Yichang Dongyangguang Changjiang Pharmaceutical Co., Ltd., Livzon Group Livzon Pharmaceutical Factory, Zhejiang Jinhua Kangenbei Biopharmaceutical Co., Ltd., Yueyang Xinhuada Pharmaceutical Co., Ltd., Anhui Taienkang Pharmaceutical Co., Ltd., Zhejiang Jingxin Pharmaceutical Co., Ltd., Wanquan Wante Pharmaceutical Jiangsu Co., Ltd., Shijiazhuang Pharmaceutical Group Ouyi Pharmaceutical Co., Ltd., Sichuan Xinston Pharmaceutical Co., Ltd., Shaoxing Jingxin Pharmaceutical Co., Ltd., Niksan Pharmaceutical, Pfizer Inc, Eisai Inc., Reddy's Laboratories, Forest Laboratories, Inc
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Anti-dementia Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Anti-dementia Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Anti-dementia Drugs Market report?

Ans: The main players in the Anti-dementia Drugs Market are Jiangsu Hausen Pharmaceutical Group Co., Ltd., Zhien Biotechnology Co., Ltd., Zhejiang Huahai Pharmaceutical Co., Ltd., Jinri Pharmaceutical (China) Co., Ltd., Shandong Luoxin Pharmaceutical Group Co., Ltd., Chengdu Tongde Pharmaceutical Co., Ltd., Disa Pharmaceutical Group Co., Ltd., Zhejiang Hisun Pharmaceutical Co., Ltd., Zhejiang Yixin Pharmaceutical Co., Ltd., Yichang Dongyangguang Changjiang Pharmaceutical Co., Ltd., Livzon Group Livzon Pharmaceutical Factory, Zhejiang Jinhua Kangenbei Biopharmaceutical Co., Ltd., Yueyang Xinhuada Pharmaceutical Co., Ltd., Anhui Taienkang Pharmaceutical Co., Ltd., Zhejiang Jingxin Pharmaceutical Co., Ltd., Wanquan Wante Pharmaceutical Jiangsu Co., Ltd., Shijiazhuang Pharmaceutical Group Ouyi Pharmaceutical Co., Ltd., Sichuan Xinston Pharmaceutical Co., Ltd., Shaoxing Jingxin Pharmaceutical Co., Ltd., Niksan Pharmaceutical, Pfizer Inc, Eisai Inc., Reddy's Laboratories, Forest Laboratories, Inc

What are the Application segmentation covered in the Anti-dementia Drugs Market report?

Ans: The Applications covered in the Anti-dementia Drugs Market report are Hospital, Clinic, Pharmacy, Other

What are the Type segmentation covered in the Anti-dementia Drugs Market report?

Ans: The Types covered in the Anti-dementia Drugs Market report are Donepezil, Galantamine, Rivastigmine, Memantine, Other

1 Anti-dementia Drugs Market Overview

1.1 Product Definition

1.2 Anti-dementia Drugs by Type

1.2.1 Global Anti-dementia Drugs Market Value Comparison by Type (2024-2030)

1.2.2 Donepezil

1.2.3 Galantamine

1.2.4 Rivastigmine

1.2.5 Memantine

1.2.6 Other

1.3 Anti-dementia Drugs by Application

1.3.1 Global Anti-dementia Drugs Market Value by Application (2024-2030)

1.3.2 Hospital

1.3.3 Clinic

1.3.4 Pharmacy

1.3.5 Other

1.4 Global Anti-dementia Drugs Market Size Estimates and Forecasts

1.4.1 Global Anti-dementia Drugs Revenue 2019-2030

1.4.2 Global Anti-dementia Drugs Sales 2019-2030

1.4.3 Global Anti-dementia Drugs Market Average Price (2019-2030)

1.5 Assumptions and Limitations

2 Anti-dementia Drugs Market Competition by Manufacturers

2.1 Global Anti-dementia Drugs Sales Market Share by Manufacturers (2019-2024)

2.2 Global Anti-dementia Drugs Revenue Market Share by Manufacturers (2019-2024)

2.3 Global Anti-dementia Drugs Average Price by Manufacturers (2019-2024)

2.4 Global Key Players of Anti-dementia Drugs, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Anti-dementia Drugs, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Anti-dementia Drugs, Product Type & Application

2.7 Global Key Manufacturers of Anti-dementia Drugs, Date of Enter into This Industry

2.8 Global Anti-dementia Drugs Market Competitive Situation and Trends

2.8.1 Global Anti-dementia Drugs Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Anti-dementia Drugs Players Market Share by Revenue

2.8.3 Global Anti-dementia Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Anti-dementia Drugs Market Scenario by Region

3.1 Global Anti-dementia Drugs Market Size by Region: 2019 Versus 2023 Versus 2030

3.2 Global Anti-dementia Drugs Sales by Region: 2019-2030

3.2.1 Global Anti-dementia Drugs Sales by Region: 2019-2024

3.2.2 Global Anti-dementia Drugs Sales by Region: 2025-2030

3.3 Global Anti-dementia Drugs Revenue by Region: 2019-2030

3.3.1 Global Anti-dementia Drugs Revenue by Region: 2019-2024

3.3.2 Global Anti-dementia Drugs Revenue by Region: 2025-2030

3.4 North America Anti-dementia Drugs Market Facts & Figures by Country

3.4.1 North America Anti-dementia Drugs Market Size by Country: 2019 VS 2023 VS 2030

3.4.2 North America Anti-dementia Drugs Sales by Country (2019-2030)

3.4.3 North America Anti-dementia Drugs Revenue by Country (2019-2030)

3.4.4 United States

3.4.5 Canada

3.5 Europe Anti-dementia Drugs Market Facts & Figures by Country

3.5.1 Europe Anti-dementia Drugs Market Size by Country: 2019 VS 2023 VS 2030

3.5.2 Europe Anti-dementia Drugs Sales by Country (2019-2030)

3.5.3 Europe Anti-dementia Drugs Revenue by Country (2019-2030)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Anti-dementia Drugs Market Facts & Figures by Region

3.6.1 Asia Pacific Anti-dementia Drugs Market Size by Region: 2019 VS 2023 VS 2030

3.6.2 Asia Pacific Anti-dementia Drugs Sales by Region (2019-2030)

3.6.3 Asia Pacific Anti-dementia Drugs Revenue by Region (2019-2030)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Southeast Asia

3.7 Latin America Anti-dementia Drugs Market Facts & Figures by Country

3.7.1 Latin America Anti-dementia Drugs Market Size by Country: 2019 VS 2023 VS 2030

3.7.2 Latin America Anti-dementia Drugs Sales by Country (2019-2030)

3.7.3 Latin America Anti-dementia Drugs Revenue by Country

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.7.7 Colombia

3.8 Middle East and Africa Anti-dementia Drugs Market Facts & Figures by Country

3.8.1 Middle East and Africa Anti-dementia Drugs Market Size by Country: 2019 VS 2023 VS 2030

3.8.2 Middle East and Africa Anti-dementia Drugs Sales by Country (2019-2030)

3.8.3 Middle East and Africa Anti-dementia Drugs Revenue by Country

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Anti-dementia Drugs Sales by Type (2019-2030)

4.1.1 Global Anti-dementia Drugs Sales by Type (2019-2024)

4.1.2 Global Anti-dementia Drugs Sales by Type (2025-2030)

4.1.3 Global Anti-dementia Drugs Sales Market Share by Type (2019-2030)

4.2 Global Anti-dementia Drugs Revenue by Type (2019-2030)

4.2.1 Global Anti-dementia Drugs Revenue by Type (2019-2024)

4.2.2 Global Anti-dementia Drugs Revenue by Type (2025-2030)

4.2.3 Global Anti-dementia Drugs Revenue Market Share by Type (2019-2030)

4.3 Global Anti-dementia Drugs Price by Type (2019-2030)

5 Segment by Application

5.1 Global Anti-dementia Drugs Sales by Application (2019-2030)

5.1.1 Global Anti-dementia Drugs Sales by Application (2019-2024)

5.1.2 Global Anti-dementia Drugs Sales by Application (2025-2030)

5.1.3 Global Anti-dementia Drugs Sales Market Share by Application (2019-2030)

5.2 Global Anti-dementia Drugs Revenue by Application (2019-2030)

5.2.1 Global Anti-dementia Drugs Revenue by Application (2019-2024)

5.2.2 Global Anti-dementia Drugs Revenue by Application (2025-2030)

5.2.3 Global Anti-dementia Drugs Revenue Market Share by Application (2019-2030)

5.3 Global Anti-dementia Drugs Price by Application (2019-2030)

6 Key Companies Profiled

6.1 Jiangsu Hausen Pharmaceutical Group Co., Ltd.

6.1.1 Jiangsu Hausen Pharmaceutical Group Co., Ltd. Company Information

6.1.2 Jiangsu Hausen Pharmaceutical Group Co., Ltd. Description and Business Overview

6.1.3 Jiangsu Hausen Pharmaceutical Group Co., Ltd. Anti-dementia Drugs Sales, Revenue and Gross Margin (2019-2024)

6.1.4 Jiangsu Hausen Pharmaceutical Group Co., Ltd. Anti-dementia Drugs Product Portfolio

6.1.5 Jiangsu Hausen Pharmaceutical Group Co., Ltd. Recent Developments/Updates

6.2 Zhien Biotechnology Co., Ltd.

6.2.1 Zhien Biotechnology Co., Ltd. Company Information

6.2.2 Zhien Biotechnology Co., Ltd. Description and Business Overview

6.2.3 Zhien Biotechnology Co., Ltd. Anti-dementia Drugs Sales, Revenue and Gross Margin (2019-2024)

6.2.4 Zhien Biotechnology Co., Ltd. Anti-dementia Drugs Product Portfolio

6.2.5 Zhien Biotechnology Co., Ltd. Recent Developments/Updates

6.3 Zhejiang Huahai Pharmaceutical Co., Ltd.

6.3.1 Zhejiang Huahai Pharmaceutical Co., Ltd. Company Information

6.3.2 Zhejiang Huahai Pharmaceutical Co., Ltd. Description and Business Overview

6.3.3 Zhejiang Huahai Pharmaceutical Co., Ltd. Anti-dementia Drugs Sales, Revenue and Gross Margin (2019-2024)

6.3.4 Zhejiang Huahai Pharmaceutical Co., Ltd. Anti-dementia Drugs Product Portfolio

6.3.5 Zhejiang Huahai Pharmaceutical Co., Ltd. Recent Developments/Updates

6.4 Jinri Pharmaceutical (China) Co., Ltd.

6.4.1 Jinri Pharmaceutical (China) Co., Ltd. Company Information

6.4.2 Jinri Pharmaceutical (China) Co., Ltd. Description and Business Overview

6.4.3 Jinri Pharmaceutical (China) Co., Ltd. Anti-dementia Drugs Sales, Revenue and Gross Margin (2019-2024)

6.4.4 Jinri Pharmaceutical (China) Co., Ltd. Anti-dementia Drugs Product Portfolio

6.4.5 Jinri Pharmaceutical (China) Co., Ltd. Recent Developments/Updates

6.5 Shandong Luoxin Pharmaceutical Group Co., Ltd.

6.5.1 Shandong Luoxin Pharmaceutical Group Co., Ltd. Company Information

6.5.2 Shandong Luoxin Pharmaceutical Group Co., Ltd. Description and Business Overview

6.5.3 Shandong Luoxin Pharmaceutical Group Co., Ltd. Anti-dementia Drugs Sales, Revenue and Gross Margin (2019-2024)

6.5.4 Shandong Luoxin Pharmaceutical Group Co., Ltd. Anti-dementia Drugs Product Portfolio

6.5.5 Shandong Luoxin Pharmaceutical Group Co., Ltd. Recent Developments/Updates

6.6 Chengdu Tongde Pharmaceutical Co., Ltd.

6.6.1 Chengdu Tongde Pharmaceutical Co., Ltd. Company Information

6.6.2 Chengdu Tongde Pharmaceutical Co., Ltd. Description and Business Overview

6.6.3 Chengdu Tongde Pharmaceutical Co., Ltd. Anti-dementia Drugs Sales, Revenue and Gross Margin (2019-2024)

6.6.4 Chengdu Tongde Pharmaceutical Co., Ltd. Anti-dementia Drugs Product Portfolio

6.6.5 Chengdu Tongde Pharmaceutical Co., Ltd. Recent Developments/Updates

6.7 Disa Pharmaceutical Group Co., Ltd.

6.7.1 Disa Pharmaceutical Group Co., Ltd. Company Information

6.7.2 Disa Pharmaceutical Group Co., Ltd. Description and Business Overview

6.7.3 Disa Pharmaceutical Group Co., Ltd. Anti-dementia Drugs Sales, Revenue and Gross Margin (2019-2024)

6.7.4 Disa Pharmaceutical Group Co., Ltd. Anti-dementia Drugs Product Portfolio

6.7.5 Disa Pharmaceutical Group Co., Ltd. Recent Developments/Updates

6.8 Zhejiang Hisun Pharmaceutical Co., Ltd.

6.8.1 Zhejiang Hisun Pharmaceutical Co., Ltd. Company Information

6.8.2 Zhejiang Hisun Pharmaceutical Co., Ltd. Description and Business Overview

6.8.3 Zhejiang Hisun Pharmaceutical Co., Ltd. Anti-dementia Drugs Sales, Revenue and Gross Margin (2019-2024)

6.8.4 Zhejiang Hisun Pharmaceutical Co., Ltd. Anti-dementia Drugs Product Portfolio

6.8.5 Zhejiang Hisun Pharmaceutical Co., Ltd. Recent Developments/Updates

6.9 Zhejiang Yixin Pharmaceutical Co., Ltd.

6.9.1 Zhejiang Yixin Pharmaceutical Co., Ltd. Company Information

6.9.2 Zhejiang Yixin Pharmaceutical Co., Ltd. Description and Business Overview

6.9.3 Zhejiang Yixin Pharmaceutical Co., Ltd. Anti-dementia Drugs Sales, Revenue and Gross Margin (2019-2024)

6.9.4 Zhejiang Yixin Pharmaceutical Co., Ltd. Anti-dementia Drugs Product Portfolio

6.9.5 Zhejiang Yixin Pharmaceutical Co., Ltd. Recent Developments/Updates

6.10 Yichang Dongyangguang Changjiang Pharmaceutical Co., Ltd.

6.10.1 Yichang Dongyangguang Changjiang Pharmaceutical Co., Ltd. Company Information

6.10.2 Yichang Dongyangguang Changjiang Pharmaceutical Co., Ltd. Description and Business Overview

6.10.3 Yichang Dongyangguang Changjiang Pharmaceutical Co., Ltd. Anti-dementia Drugs Sales, Revenue and Gross Margin (2019-2024)

6.10.4 Yichang Dongyangguang Changjiang Pharmaceutical Co., Ltd. Anti-dementia Drugs Product Portfolio

6.10.5 Yichang Dongyangguang Changjiang Pharmaceutical Co., Ltd. Recent Developments/Updates

6.11 Livzon Group Livzon Pharmaceutical Factory

6.11.1 Livzon Group Livzon Pharmaceutical Factory Company Information

6.11.2 Livzon Group Livzon Pharmaceutical Factory Description and Business Overview

6.11.3 Livzon Group Livzon Pharmaceutical Factory Anti-dementia Drugs Sales, Revenue and Gross Margin (2019-2024)

6.11.4 Livzon Group Livzon Pharmaceutical Factory Anti-dementia Drugs Product Portfolio

6.11.5 Livzon Group Livzon Pharmaceutical Factory Recent Developments/Updates

6.12 Zhejiang Jinhua Kangenbei Biopharmaceutical Co., Ltd.

6.12.1 Zhejiang Jinhua Kangenbei Biopharmaceutical Co., Ltd. Company Information

6.12.2 Zhejiang Jinhua Kangenbei Biopharmaceutical Co., Ltd. Description and Business Overview

6.12.3 Zhejiang Jinhua Kangenbei Biopharmaceutical Co., Ltd. Anti-dementia Drugs Sales, Revenue and Gross Margin (2019-2024)

6.12.4 Zhejiang Jinhua Kangenbei Biopharmaceutical Co., Ltd. Anti-dementia Drugs Product Portfolio

6.12.5 Zhejiang Jinhua Kangenbei Biopharmaceutical Co., Ltd. Recent Developments/Updates

6.13 Yueyang Xinhuada Pharmaceutical Co., Ltd.

6.13.1 Yueyang Xinhuada Pharmaceutical Co., Ltd. Company Information

6.13.2 Yueyang Xinhuada Pharmaceutical Co., Ltd. Description and Business Overview

6.13.3 Yueyang Xinhuada Pharmaceutical Co., Ltd. Anti-dementia Drugs Sales, Revenue and Gross Margin (2019-2024)

6.13.4 Yueyang Xinhuada Pharmaceutical Co., Ltd. Anti-dementia Drugs Product Portfolio

6.13.5 Yueyang Xinhuada Pharmaceutical Co., Ltd. Recent Developments/Updates

6.14 Anhui Taienkang Pharmaceutical Co., Ltd.

6.14.1 Anhui Taienkang Pharmaceutical Co., Ltd. Company Information

6.14.2 Anhui Taienkang Pharmaceutical Co., Ltd. Description and Business Overview

6.14.3 Anhui Taienkang Pharmaceutical Co., Ltd. Anti-dementia Drugs Sales, Revenue and Gross Margin (2019-2024)

6.14.4 Anhui Taienkang Pharmaceutical Co., Ltd. Anti-dementia Drugs Product Portfolio

6.14.5 Anhui Taienkang Pharmaceutical Co., Ltd. Recent Developments/Updates

6.15 Zhejiang Jingxin Pharmaceutical Co., Ltd.

6.15.1 Zhejiang Jingxin Pharmaceutical Co., Ltd. Company Information

6.15.2 Zhejiang Jingxin Pharmaceutical Co., Ltd. Description and Business Overview

6.15.3 Zhejiang Jingxin Pharmaceutical Co., Ltd. Anti-dementia Drugs Sales, Revenue and Gross Margin (2019-2024)

6.15.4 Zhejiang Jingxin Pharmaceutical Co., Ltd. Anti-dementia Drugs Product Portfolio

6.15.5 Zhejiang Jingxin Pharmaceutical Co., Ltd. Recent Developments/Updates

6.16 Wanquan Wante Pharmaceutical Jiangsu Co., Ltd.

6.16.1 Wanquan Wante Pharmaceutical Jiangsu Co., Ltd. Company Information

6.16.2 Wanquan Wante Pharmaceutical Jiangsu Co., Ltd. Description and Business Overview

6.16.3 Wanquan Wante Pharmaceutical Jiangsu Co., Ltd. Anti-dementia Drugs Sales, Revenue and Gross Margin (2019-2024)

6.16.4 Wanquan Wante Pharmaceutical Jiangsu Co., Ltd. Anti-dementia Drugs Product Portfolio

6.16.5 Wanquan Wante Pharmaceutical Jiangsu Co., Ltd. Recent Developments/Updates

6.17 Shijiazhuang Pharmaceutical Group Ouyi Pharmaceutical Co., Ltd.

6.17.1 Shijiazhuang Pharmaceutical Group Ouyi Pharmaceutical Co., Ltd. Company Information

6.17.2 Shijiazhuang Pharmaceutical Group Ouyi Pharmaceutical Co., Ltd. Description and Business Overview

6.17.3 Shijiazhuang Pharmaceutical Group Ouyi Pharmaceutical Co., Ltd. Anti-dementia Drugs Sales, Revenue and Gross Margin (2019-2024)

6.17.4 Shijiazhuang Pharmaceutical Group Ouyi Pharmaceutical Co., Ltd. Anti-dementia Drugs Product Portfolio

6.17.5 Shijiazhuang Pharmaceutical Group Ouyi Pharmaceutical Co., Ltd. Recent Developments/Updates

6.18 Sichuan Xinston Pharmaceutical Co., Ltd.

6.18.1 Sichuan Xinston Pharmaceutical Co., Ltd. Company Information

6.18.2 Sichuan Xinston Pharmaceutical Co., Ltd. Description and Business Overview

6.18.3 Sichuan Xinston Pharmaceutical Co., Ltd. Anti-dementia Drugs Sales, Revenue and Gross Margin (2019-2024)

6.18.4 Sichuan Xinston Pharmaceutical Co., Ltd. Anti-dementia Drugs Product Portfolio

6.18.5 Sichuan Xinston Pharmaceutical Co., Ltd. Recent Developments/Updates

6.19 Shaoxing Jingxin Pharmaceutical Co., Ltd.

6.19.1 Shaoxing Jingxin Pharmaceutical Co., Ltd. Company Information

6.19.2 Shaoxing Jingxin Pharmaceutical Co., Ltd. Description and Business Overview

6.19.3 Shaoxing Jingxin Pharmaceutical Co., Ltd. Anti-dementia Drugs Sales, Revenue and Gross Margin (2019-2024)

6.19.4 Shaoxing Jingxin Pharmaceutical Co., Ltd. Anti-dementia Drugs Product Portfolio

6.19.5 Shaoxing Jingxin Pharmaceutical Co., Ltd. Recent Developments/Updates

6.20 Niksan Pharmaceutical

6.20.1 Niksan Pharmaceutical Company Information

6.20.2 Niksan Pharmaceutical Description and Business Overview

6.20.3 Niksan Pharmaceutical Anti-dementia Drugs Sales, Revenue and Gross Margin (2019-2024)

6.20.4 Niksan Pharmaceutical Anti-dementia Drugs Product Portfolio

6.20.5 Niksan Pharmaceutical Recent Developments/Updates

6.21 Pfizer Inc

6.21.1 Pfizer Inc Company Information

6.21.2 Pfizer Inc Description and Business Overview

6.21.3 Pfizer Inc Anti-dementia Drugs Sales, Revenue and Gross Margin (2019-2024)

6.21.4 Pfizer Inc Anti-dementia Drugs Product Portfolio

6.21.5 Pfizer Inc Recent Developments/Updates

6.22 Eisai Inc.

6.22.1 Eisai Inc. Company Information

6.22.2 Eisai Inc. Description and Business Overview

6.22.3 Eisai Inc. Anti-dementia Drugs Sales, Revenue and Gross Margin (2019-2024)

6.22.4 Eisai Inc. Anti-dementia Drugs Product Portfolio

6.22.5 Eisai Inc. Recent Developments/Updates

6.23 Reddy's Laboratories

6.23.1 Reddy's Laboratories Company Information

6.23.2 Reddy's Laboratories Description and Business Overview

6.23.3 Reddy's Laboratories Anti-dementia Drugs Sales, Revenue and Gross Margin (2019-2024)

6.23.4 Reddy's Laboratories Anti-dementia Drugs Product Portfolio

6.23.5 Reddy's Laboratories Recent Developments/Updates

6.24 Forest Laboratories, Inc

6.24.1 Forest Laboratories, Inc Company Information

6.24.2 Forest Laboratories, Inc Description and Business Overview

6.24.3 Forest Laboratories, Inc Anti-dementia Drugs Sales, Revenue and Gross Margin (2019-2024)

6.24.4 Forest Laboratories, Inc Anti-dementia Drugs Product Portfolio

6.24.5 Forest Laboratories, Inc Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Anti-dementia Drugs Industry Chain Analysis

7.2 Anti-dementia Drugs Key Raw Materials

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Anti-dementia Drugs Production Mode & Process

7.4 Anti-dementia Drugs Sales and Marketing

7.4.1 Anti-dementia Drugs Sales Channels

7.4.2 Anti-dementia Drugs Distributors

7.5 Anti-dementia Drugs Customers

8 Anti-dementia Drugs Market Dynamics

8.1 Anti-dementia Drugs Industry Trends

8.2 Anti-dementia Drugs Market Drivers

8.3 Anti-dementia Drugs Market Challenges

8.4 Anti-dementia Drugs Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Jiangsu Hausen Pharmaceutical Group Co., Ltd.

Zhejiang Huahai Pharmaceutical Co., Ltd.

JINRI Pharmaceutical (CHINA) Co., Ltd.

Shandong Luoxin Pharmaceutical Group Co. LTD

Chengdu Tongde Pharmaceutical Co., Ltd.

Disa Pharmaceutical Group Co., Ltd.

Zhejiang Hisun Pharmaceutical Co Ltd

Zhejiang Yixin Pharmaceutical Co., Ltd.

Livzon Group Livzon Pharmaceutical Factory

Zhejiang Jinhua Kangenbei Biopharmaceutical Co., Ltd.

Anhui Taienkang Pharmaceutical Co., Ltd.

Zhejiang Jingxin Pharmaceutical Co., Ltd

Shijiazhuang Pharmaceutical Group Ouyi Pharmaceutical Co., Ltd.

Shaoxing Jingxin Pharmaceutical Co., Ltd.

NIKSAN PHARMACEUTICAL

Pfizer Inc

Eisai Co Ltd

Reddy's Laboratories

Forest Laboratories, Inc.

Zhien Biotechnology Co., Ltd.

Yichang Dongyangguang Changjiang Pharmaceutical Co., Ltd.

Yueyang Xinhuada Pharmaceutical Co., Ltd.

Wanquan Wante Pharmaceutical Jiangsu Co., Ltd.

Sichuan Xinston Pharmaceutical Co., Ltd.

List of Tables

Table 1. Global Anti-dementia Drugs Market Value Comparison by Type (2024-2030) & (US$ Million)

Table 2. Global Anti-dementia Drugs Market Value by Application (2024-2030) & (US$ Million)

Table 3. Global Anti-dementia Drugs Market Competitive Situation by Manufacturers in 2023

Table 4. Global Anti-dementia Drugs Sales (K Units) of Key Manufacturers (2019-2024)

Table 5. Global Anti-dementia Drugs Sales Market Share by Manufacturers (2019-2024)

Table 6. Global Anti-dementia Drugs Revenue (US$ Million) by Manufacturers (2019-2024)

Table 7. Global Anti-dementia Drugs Revenue Share by Manufacturers (2019-2024)

Table 8. Global Market Anti-dementia Drugs Average Price (US$/Unit) of Key Manufacturers (2019-2024)

Table 9. Global Key Players of Anti-dementia Drugs, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Anti-dementia Drugs, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Anti-dementia Drugs, Product Type & Application

Table 12. Global Key Manufacturers of Anti-dementia Drugs, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Anti-dementia Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-dementia Drugs as of 2023)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Anti-dementia Drugs Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 17. Global Anti-dementia Drugs Sales by Region (2019-2024) & (K Units)

Table 18. Global Anti-dementia Drugs Sales Market Share by Region (2019-2024)

Table 19. Global Anti-dementia Drugs Sales by Region (2025-2030) & (K Units)

Table 20. Global Anti-dementia Drugs Sales Market Share by Region (2025-2030)

Table 21. Global Anti-dementia Drugs Revenue by Region (2019-2024) & (US$ Million)

Table 22. Global Anti-dementia Drugs Revenue Market Share by Region (2019-2024)

Table 23. Global Anti-dementia Drugs Revenue by Region (2025-2030) & (US$ Million)

Table 24. Global Anti-dementia Drugs Revenue Market Share by Region (2025-2030)

Table 25. North America Anti-dementia Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 26. North America Anti-dementia Drugs Sales by Country (2019-2024) & (K Units)

Table 27. North America Anti-dementia Drugs Sales by Country (2025-2030) & (K Units)

Table 28. North America Anti-dementia Drugs Revenue by Country (2019-2024) & (US$ Million)

Table 29. North America Anti-dementia Drugs Revenue by Country (2025-2030) & (US$ Million)

Table 30. Europe Anti-dementia Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 31. Europe Anti-dementia Drugs Sales by Country (2019-2024) & (K Units)

Table 32. Europe Anti-dementia Drugs Sales by Country (2025-2030) & (K Units)

Table 33. Europe Anti-dementia Drugs Revenue by Country (2019-2024) & (US$ Million)

Table 34. Europe Anti-dementia Drugs Revenue by Country (2025-2030) & (US$ Million)

Table 35. Asia Pacific Anti-dementia Drugs Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 36. Asia Pacific Anti-dementia Drugs Sales by Region (2019-2024) & (K Units)

Table 37. Asia Pacific Anti-dementia Drugs Sales by Region (2025-2030) & (K Units)

Table 38. Asia Pacific Anti-dementia Drugs Revenue by Region (2019-2024) & (US$ Million)

Table 39. Asia Pacific Anti-dementia Drugs Revenue by Region (2025-2030) & (US$ Million)

Table 40. Latin America Anti-dementia Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Latin America Anti-dementia Drugs Sales by Country (2019-2024) & (K Units)

Table 42. Latin America Anti-dementia Drugs Sales by Country (2025-2030) & (K Units)

Table 43. Latin America Anti-dementia Drugs Revenue by Country (2019-2024) & (US$ Million)

Table 44. Latin America Anti-dementia Drugs Revenue Market Share by Country (2019-2024)

Table 45. Middle East and Africa Anti-dementia Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 46. Middle East and Africa Anti-dementia Drugs Sales by Country (2019-2024) & (K Units)

Table 47. Middle East and Africa Anti-dementia Drugs Sales by Country (2025-2030) & (K Units)

Table 48. Middle East and Africa Anti-dementia Drugs Revenue by Country (2019-2024) & (US$ Million)

Table 49. Middle East and Africa Anti-dementia Drugs Revenue by Country (2025-2030) & (US$ Million)

Table 50. Global Anti-dementia Drugs Sales (K Units) by Type (2019-2024)

Table 51. Global Anti-dementia Drugs Sales (K Units) by Type (2025-2030)

Table 52. Global Anti-dementia Drugs Sales Market Share by Type (2019-2024)

Table 53. Global Anti-dementia Drugs Sales Market Share by Type (2025-2030)

Table 54. Global Anti-dementia Drugs Revenue (US$ Million) by Type (2019-2024)

Table 55. Global Anti-dementia Drugs Revenue (US$ Million) by Type (2025-2030)

Table 56. Global Anti-dementia Drugs Revenue Market Share by Type (2019-2024)

Table 57. Global Anti-dementia Drugs Revenue Market Share by Type (2025-2030)

Table 58. Global Anti-dementia Drugs Price (US$/Unit) by Type (2019-2024)

Table 59. Global Anti-dementia Drugs Price (US$/Unit) by Type (2025-2030)

Table 60. Global Anti-dementia Drugs Sales (K Units) by Application (2019-2024)

Table 61. Global Anti-dementia Drugs Sales (K Units) by Application (2025-2030)

Table 62. Global Anti-dementia Drugs Sales Market Share by Application (2019-2024)

Table 63. Global Anti-dementia Drugs Sales Market Share by Application (2025-2030)

Table 64. Global Anti-dementia Drugs Revenue (US$ Million) by Application (2019-2024)

Table 65. Global Anti-dementia Drugs Revenue (US$ Million) by Application (2025-2030)

Table 66. Global Anti-dementia Drugs Revenue Market Share by Application (2019-2024)

Table 67. Global Anti-dementia Drugs Revenue Market Share by Application (2025-2030)

Table 68. Global Anti-dementia Drugs Price (US$/Unit) by Application (2019-2024)

Table 69. Global Anti-dementia Drugs Price (US$/Unit) by Application (2025-2030)

Table 70. Jiangsu Hausen Pharmaceutical Group Co., Ltd. Company Information

Table 71. Jiangsu Hausen Pharmaceutical Group Co., Ltd. Description and Business Overview

Table 72. Jiangsu Hausen Pharmaceutical Group Co., Ltd. Anti-dementia Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 73. Jiangsu Hausen Pharmaceutical Group Co., Ltd. Anti-dementia Drugs Product

Table 74. Jiangsu Hausen Pharmaceutical Group Co., Ltd. Recent Developments/Updates

Table 75. Zhien Biotechnology Co., Ltd. Company Information

Table 76. Zhien Biotechnology Co., Ltd. Description and Business Overview

Table 77. Zhien Biotechnology Co., Ltd. Anti-dementia Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 78. Zhien Biotechnology Co., Ltd. Anti-dementia Drugs Product

Table 79. Zhien Biotechnology Co., Ltd. Recent Developments/Updates

Table 80. Zhejiang Huahai Pharmaceutical Co., Ltd. Company Information

Table 81. Zhejiang Huahai Pharmaceutical Co., Ltd. Description and Business Overview

Table 82. Zhejiang Huahai Pharmaceutical Co., Ltd. Anti-dementia Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 83. Zhejiang Huahai Pharmaceutical Co., Ltd. Anti-dementia Drugs Product

Table 84. Zhejiang Huahai Pharmaceutical Co., Ltd. Recent Developments/Updates

Table 85. Jinri Pharmaceutical (China) Co., Ltd. Company Information

Table 86. Jinri Pharmaceutical (China) Co., Ltd. Description and Business Overview

Table 87. Jinri Pharmaceutical (China) Co., Ltd. Anti-dementia Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 88. Jinri Pharmaceutical (China) Co., Ltd. Anti-dementia Drugs Product

Table 89. Jinri Pharmaceutical (China) Co., Ltd. Recent Developments/Updates

Table 90. Shandong Luoxin Pharmaceutical Group Co., Ltd. Company Information

Table 91. Shandong Luoxin Pharmaceutical Group Co., Ltd. Description and Business Overview

Table 92. Shandong Luoxin Pharmaceutical Group Co., Ltd. Anti-dementia Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 93. Shandong Luoxin Pharmaceutical Group Co., Ltd. Anti-dementia Drugs Product

Table 94. Shandong Luoxin Pharmaceutical Group Co., Ltd. Recent Developments/Updates

Table 95. Chengdu Tongde Pharmaceutical Co., Ltd. Company Information

Table 96. Chengdu Tongde Pharmaceutical Co., Ltd. Description and Business Overview

Table 97. Chengdu Tongde Pharmaceutical Co., Ltd. Anti-dementia Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 98. Chengdu Tongde Pharmaceutical Co., Ltd. Anti-dementia Drugs Product

Table 99. Chengdu Tongde Pharmaceutical Co., Ltd. Recent Developments/Updates

Table 100. Disa Pharmaceutical Group Co., Ltd. Company Information

Table 101. Disa Pharmaceutical Group Co., Ltd. Description and Business Overview

Table 102. Disa Pharmaceutical Group Co., Ltd. Anti-dementia Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 103. Disa Pharmaceutical Group Co., Ltd. Anti-dementia Drugs Product

Table 104. Disa Pharmaceutical Group Co., Ltd. Recent Developments/Updates

Table 105. Zhejiang Hisun Pharmaceutical Co., Ltd. Company Information

Table 106. Zhejiang Hisun Pharmaceutical Co., Ltd. Description and Business Overview

Table 107. Zhejiang Hisun Pharmaceutical Co., Ltd. Anti-dementia Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 108. Zhejiang Hisun Pharmaceutical Co., Ltd. Anti-dementia Drugs Product

Table 109. Zhejiang Hisun Pharmaceutical Co., Ltd. Recent Developments/Updates

Table 110. Zhejiang Yixin Pharmaceutical Co., Ltd. Company Information

Table 111. Zhejiang Yixin Pharmaceutical Co., Ltd. Description and Business Overview

Table 112. Zhejiang Yixin Pharmaceutical Co., Ltd. Anti-dementia Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 113. Zhejiang Yixin Pharmaceutical Co., Ltd. Anti-dementia Drugs Product

Table 114. Zhejiang Yixin Pharmaceutical Co., Ltd. Recent Developments/Updates

Table 115. Yichang Dongyangguang Changjiang Pharmaceutical Co., Ltd. Company Information

Table 116. Yichang Dongyangguang Changjiang Pharmaceutical Co., Ltd. Description and Business Overview

Table 117. Yichang Dongyangguang Changjiang Pharmaceutical Co., Ltd. Anti-dementia Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 118. Yichang Dongyangguang Changjiang Pharmaceutical Co., Ltd. Anti-dementia Drugs Product

Table 119. Yichang Dongyangguang Changjiang Pharmaceutical Co., Ltd. Recent Developments/Updates

Table 120. Livzon Group Livzon Pharmaceutical Factory Company Information

Table 121. Livzon Group Livzon Pharmaceutical Factory Description and Business Overview

Table 122. Livzon Group Livzon Pharmaceutical Factory Anti-dementia Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 123. Livzon Group Livzon Pharmaceutical Factory Anti-dementia Drugs Product

Table 124. Livzon Group Livzon Pharmaceutical Factory Recent Developments/Updates

Table 125. Zhejiang Jinhua Kangenbei Biopharmaceutical Co., Ltd. Company Information

Table 126. Zhejiang Jinhua Kangenbei Biopharmaceutical Co., Ltd. Description and Business Overview

Table 127. Zhejiang Jinhua Kangenbei Biopharmaceutical Co., Ltd. Anti-dementia Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 128. Zhejiang Jinhua Kangenbei Biopharmaceutical Co., Ltd. Anti-dementia Drugs Product

Table 129. Zhejiang Jinhua Kangenbei Biopharmaceutical Co., Ltd. Recent Developments/Updates

Table 130. Yueyang Xinhuada Pharmaceutical Co., Ltd. Company Information

Table 131. Yueyang Xinhuada Pharmaceutical Co., Ltd. Description and Business Overview

Table 132. Yueyang Xinhuada Pharmaceutical Co., Ltd. Anti-dementia Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 133. Yueyang Xinhuada Pharmaceutical Co., Ltd. Anti-dementia Drugs Product

Table 134. Yueyang Xinhuada Pharmaceutical Co., Ltd. Recent Developments/Updates

Table 135. Anhui Taienkang Pharmaceutical Co., Ltd. Company Information

Table 136. Anhui Taienkang Pharmaceutical Co., Ltd. Description and Business Overview

Table 137. Anhui Taienkang Pharmaceutical Co., Ltd. Anti-dementia Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 138. Anhui Taienkang Pharmaceutical Co., Ltd. Anti-dementia Drugs Product

Table 139. Anhui Taienkang Pharmaceutical Co., Ltd. Recent Developments/Updates

Table 140. Zhejiang Jingxin Pharmaceutical Co., Ltd. Company Information

Table 141. Zhejiang Jingxin Pharmaceutical Co., Ltd. Description and Business Overview

Table 142. Zhejiang Jingxin Pharmaceutical Co., Ltd. Anti-dementia Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 143. Zhejiang Jingxin Pharmaceutical Co., Ltd. Anti-dementia Drugs Product

Table 144. Zhejiang Jingxin Pharmaceutical Co., Ltd. Recent Developments/Updates

Table 145. Wanquan Wante Pharmaceutical Jiangsu Co., Ltd. Company Information

Table 146. Wanquan Wante Pharmaceutical Jiangsu Co., Ltd. Description and Business Overview

Table 147. Wanquan Wante Pharmaceutical Jiangsu Co., Ltd. Anti-dementia Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 148. Wanquan Wante Pharmaceutical Jiangsu Co., Ltd. Anti-dementia Drugs Product

Table 149. Wanquan Wante Pharmaceutical Jiangsu Co., Ltd. Recent Developments/Updates

Table 150. Shijiazhuang Pharmaceutical Group Ouyi Pharmaceutical Co., Ltd. Company Information

Table 151. Shijiazhuang Pharmaceutical Group Ouyi Pharmaceutical Co., Ltd. Description and Business Overview

Table 152. Shijiazhuang Pharmaceutical Group Ouyi Pharmaceutical Co., Ltd. Anti-dementia Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 153. Shijiazhuang Pharmaceutical Group Ouyi Pharmaceutical Co., Ltd. Anti-dementia Drugs Product

Table 154. Shijiazhuang Pharmaceutical Group Ouyi Pharmaceutical Co., Ltd. Recent Developments/Updates

Table 155. Sichuan Xinston Pharmaceutical Co., Ltd. Company Information

Table 156. Sichuan Xinston Pharmaceutical Co., Ltd. Description and Business Overview

Table 157. Sichuan Xinston Pharmaceutical Co., Ltd. Anti-dementia Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 158. Sichuan Xinston Pharmaceutical Co., Ltd. Anti-dementia Drugs Product

Table 159. Sichuan Xinston Pharmaceutical Co., Ltd. Recent Developments/Updates

Table 160. Shaoxing Jingxin Pharmaceutical Co., Ltd. Company Information

Table 161. Shaoxing Jingxin Pharmaceutical Co., Ltd. Description and Business Overview

Table 162. Shaoxing Jingxin Pharmaceutical Co., Ltd. Anti-dementia Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 163. Shaoxing Jingxin Pharmaceutical Co., Ltd. Anti-dementia Drugs Product

Table 164. Shaoxing Jingxin Pharmaceutical Co., Ltd. Recent Developments/Updates

Table 165. Niksan Pharmaceutical Company Information

Table 166. Niksan Pharmaceutical Description and Business Overview

Table 167. Niksan Pharmaceutical Anti-dementia Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 168. Niksan Pharmaceutical Anti-dementia Drugs Product

Table 169. Niksan Pharmaceutical Recent Developments/Updates

Table 170. Pfizer Inc Company Information

Table 171. Pfizer Inc Description and Business Overview

Table 172. Pfizer Inc Anti-dementia Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 173. Pfizer Inc Anti-dementia Drugs Product

Table 174. Pfizer Inc Recent Developments/Updates

Table 175. Eisai Inc. Company Information

Table 176. Eisai Inc. Description and Business Overview

Table 177. Eisai Inc. Anti-dementia Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 178. Eisai Inc. Anti-dementia Drugs Product

Table 179. Eisai Inc. Recent Developments/Updates

Table 180. Reddy's Laboratories Company Information

Table 181. Reddy's Laboratories Description and Business Overview

Table 182. Reddy's Laboratories Anti-dementia Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 183. Reddy's Laboratories Anti-dementia Drugs Product

Table 184. Reddy's Laboratories Recent Developments/Updates

Table 185. Forest Laboratories, Inc Company Information

Table 186. Forest Laboratories, Inc Description and Business Overview

Table 187. Forest Laboratories, Inc Anti-dementia Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 188. Forest Laboratories, Inc Anti-dementia Drugs Product

Table 189. Forest Laboratories, Inc Recent Developments/Updates

Table 190. Key Raw Materials Lists

Table 191. Raw Materials Key Suppliers Lists

Table 192. Anti-dementia Drugs Distributors List

Table 193. Anti-dementia Drugs Customers List

Table 194. Anti-dementia Drugs Market Trends

Table 195. Anti-dementia Drugs Market Drivers

Table 196. Anti-dementia Drugs Market Challenges

Table 197. Anti-dementia Drugs Market Restraints

Table 198. Research Programs/Design for This Report

Table 199. Key Data Information from Secondary Sources

Table 200. Key Data Information from Primary Sources

Table 201. Authors List of This Report

List of Figures

Figure 1. Product Picture of Anti-dementia Drugs

Figure 2. Global Anti-dementia Drugs Market Value Comparison by Type (2024-2030) & (US$ Million)

Figure 3. Global Anti-dementia Drugs Market Share by Type: 2023 & 2030

Figure 4. Donepezil Product Picture

Figure 5. Galantamine Product Picture

Figure 6. Rivastigmine Product Picture

Figure 7. Memantine Product Picture

Figure 8. Other Product Picture

Figure 9. Global Anti-dementia Drugs Market Value by Application (2024-2030) & (US$ Million)

Figure 10. Global Anti-dementia Drugs Market Share by Application: 2023 & 2030

Figure 11. Hospital

Figure 12. Clinic

Figure 13. Pharmacy

Figure 14. Other

Figure 15. Global Anti-dementia Drugs Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 16. Global Anti-dementia Drugs Market Size (2019-2030) & (US$ Million)

Figure 17. Global Anti-dementia Drugs Sales (2019-2030) & (K Units)

Figure 18. Global Anti-dementia Drugs Average Price (US$/Unit) & (2019-2030)

Figure 19. Anti-dementia Drugs Report Years Considered

Figure 20. Anti-dementia Drugs Sales Share by Manufacturers in 2023

Figure 21. Global Anti-dementia Drugs Revenue Share by Manufacturers in 2023

Figure 22. Global 5 and 10 Largest Anti-dementia Drugs Players: Market Share by Revenue in Anti-dementia Drugs in 2023

Figure 23. Anti-dementia Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 24. Global Anti-dementia Drugs Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Figure 25. North America Anti-dementia Drugs Sales Market Share by Country (2019-2030)

Figure 26. North America Anti-dementia Drugs Revenue Market Share by Country (2019-2030)

Figure 27. United States Anti-dementia Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 28. Canada Anti-dementia Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 29. Europe Anti-dementia Drugs Sales Market Share by Country (2019-2030)

Figure 30. Europe Anti-dementia Drugs Revenue Market Share by Country (2019-2030)

Figure 31. Germany Anti-dementia Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 32. France Anti-dementia Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 33. U.K. Anti-dementia Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 34. Italy Anti-dementia Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 35. Russia Anti-dementia Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 36. Asia Pacific Anti-dementia Drugs Sales Market Share by Region (2019-2030)

Figure 37. Asia Pacific Anti-dementia Drugs Revenue Market Share by Region (2019-2030)

Figure 38. China Anti-dementia Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 39. Japan Anti-dementia Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 40. South Korea Anti-dementia Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 41. India Anti-dementia Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 42. Australia Anti-dementia Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 43. China Taiwan Anti-dementia Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 44. Southeast Asia Anti-dementia Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 45. Latin America Anti-dementia Drugs Sales Market Share by Country (2019-2030)

Figure 46. Mexico Anti-dementia Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 47. Brazil Anti-dementia Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 48. Argentina Anti-dementia Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 49. Colombia Anti-dementia Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 50. Middle East and Africa Anti-dementia Drugs Sales Market Share by Country (2019-2030)

Figure 51. Middle East and Africa Anti-dementia Drugs Revenue Market Share by Country (2019-2030)

Figure 52. Turkey Anti-dementia Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 53. Saudi Arabia Anti-dementia Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 54. UAE Anti-dementia Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 55. Global Sales Market Share of Anti-dementia Drugs by Type (2019-2030)

Figure 56. Global Revenue Market Share of Anti-dementia Drugs by Type (2019-2030)

Figure 57. Global Anti-dementia Drugs Price (US$/Unit) by Type (2019-2030)

Figure 58. Global Sales Market Share of Anti-dementia Drugs by Application (2019-2030)

Figure 59. Global Revenue Market Share of Anti-dementia Drugs by Application (2019-2030)

Figure 60. Global Anti-dementia Drugs Price (US$/Unit) by Application (2019-2030)

Figure 61. Anti-dementia Drugs Value Chain

Figure 62. Anti-dementia Drugs Production Process

Figure 63. Channels of Distribution (Direct Vs Distribution)

Figure 64. Bottom-up and Top-down Approaches for This Report

Figure 65. Data Triangulation

Figure 66. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions